

10:00 am EDT - 2:00 pm EDT
Past Event
10:00 am - 2:00 pm EDT
1000 H Street NW
Washington, DC
On October 25, the Engelberg Center hosted and expert workshop, “Understanding and Discussing the Implications of FDA’s Sentinel Initiative,” which focused on issues of importance for medical product developers.
This meeting brought together representatives to discuss the role of FDA’s pilot program, Mini-Sentinel, within FDA’s broader array of tools to monitor medical product safety and to discuss mechanisms for how developers could support and engage with FDA on Sentinel-related activities.
Matthew Fiedler
October 8, 2025
Marta E. Wosińska
October 8, 2025
Christen Linke Young
October 7, 2025